Edition:
United Kingdom

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

21.82USD
19 Jun 2019
Change (% chg)

$-0.14 (-0.64%)
Prev Close
$21.96
Open
$22.05
Day's High
$22.32
Day's Low
$21.62
Volume
165,333
Avg. Vol
165,707
52-wk High
$47.20
52-wk Low
$21.31

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Utpal Koppikar

49 2018 Chief Financial Officer

Joseph Newell

49 2017 Executive Vice President, Chief Technical Operations Officer

Mina Kim

45 2019 Senior Vice President, General Counsel, Secretary

Derrell Porter

48 2017 Senior Vice President,Head of Commercial

Dietmar Berger

56 2018 Global Head of Research and Development